Morphogen-ix

Provider of therapeutics for pulmonary arterial hypertension (PAH)

placeCambridge, England, United Kingdom calendar_todayFounded 2015 groups1 employees language morphogen-ix.com

Registered entities

Investor mix

4 investors on record; lead investors include Medicxi.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon